Collection
MeSH Terms
Inflammatory bowel diseases;
Therapeutic drug monitoring;
Biologics;
Keywords
Inflammatory bowel diseases;
Therapeutic drug monitoring;
Biologics;
Evidence-based multidisciplinary guideline
Therapeutic drug monitoring;
Biologics;
Evidence-based multidisciplinary guideline
Date for Review
01/10/2024
Expected Publication Date
01/01/2025
Date of Last Evidence Search
15/12/2023
Methods Applied
Systematic review; Evidence synthesis; GRADE assessment of quality of evidence; GRADE evidence to decision framework; GRADE adolopment;
Guideline Contact
Yu Zhang, whxhzy@163.com
Publication Scope
Individualized therapy in biologics of inflammatory bowel disease
Countries of Application
Asia-Pacific countries
Guideline Publication Status
Development
Languages
English
Willingness to Collaborate
Yes
Name of Endorsing Organization
Chinese Pharmaceutical Association Hospital Pharmacy Professional Committee, Inflammatory Bowel Disease Group, Chinese Society of Gastroenterology, Chinese Medical Association, Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society, Chin